Labordiagnostik in der Intensivmedizin

Kernaussagen

• Die Labordiagnostik hat einen Anteil von 7 – 9 % an den Gesamtkosten der Intensivmedizin.

• Blutentnahmen für die Labordiagnostik führen bei Intensivpatienten zu signifikanten Blutverlusten.

• Labortest sollte man nicht in regelmäßigen Abständen, sondern nur zur Klärung spezifischer klinischer Fragestellungen anordnen.

• Es ist darauf zu achten, dass Fehler in der prä- und postanalytischen Phase vermieden werden.

• Die Sinnhaftigkeit und die Kosten der Labordiagnostik auf der Intensivstation sollten in festen Abständen überprüft werden.

• Literatur

• 1 Halwachs-Baumann G. Labormedizin. Wien New York: Springer; 2011
• 2 Thomas L. Labor und Diagnose. Frankfurt am Main: Th–Books; 2012
• 3 Renz HH. Praktische Labordiagnostik. München: De Gruyter; 2014
• 4 Vincent JL, Baron JF, Reinhart K et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-1507
• 5 Moerer O, Plock E, Mgbor U et al. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care 2007; 11: R69
• 6 Halpern SD, Becker D, Curtis JR et al. An official American Thoracic Society/American Association of Critical-Care Nurses/American College of Chest Physicians/Society of Crit Care Med policy statement: the Choosing Wisely(R) Top 5 list in Crit Care Med. Am J Respir Crit Care Med 2014; 190: 818-826
• 7 Pretto JJ, Rochford PD. Effects of sample storage time, temperature and syringe type on blood gas tensions in samples with high oxygen partial pressures. Thorax 1994; 49: 610-612
• 8 Dellinger RP, Levy M, Rhodes A. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013; 41: 580-637
• 9 ProCess Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683-1693
• 10 Arise Investigators, Anzics Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014; 371: 1496-1506
• 11 Mouncey PR, Osborn TM, Power GS et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015; 372: 1301-1311
• 12 Siggaard-Andersen O. The acid-base status of the blood. Copenhagen: Munksgaard; 1974
• 13 Deetjen P, Lichtwarck-Aschoff M. Practical diagnostics of acid-base disorders: part I: differentiation between respiratory and metabolic disturbances. Anaesthesist 2012; 61: 989-1000
• 14 Deetjen P, Lichtwarck-Aschoff M. Practical diagnostics of acid-base disorders. Part II: Complex metabolic disturbances. Anaesthesist 2012; 61: 1067-1076
• 15 Corey HE. Bench-to-bedside review: Fundamental principles of acid-base physiology. Crit Care 2005; 9: 184-192
• 16 Lichtwarck-Aschoff M, Dietrich B, Breitschaft D. Disorders of water and sodium balance in intensive care patients. Anaesthesist 2009; 58: 543-560
• 17 Sterns RH, Silver S, Kleinschmidt-DeMasters BK et al. Current perspectives in the management of hyponatremia: prevention of CPM. Expert Rev Neurother 2007; 7: 1791-1797
• 18 Dasta JF, Chiong JR, Christian R et al. Update on tolvaptan for the treatment of hyponatremia. Expert review of pharmacoeconomics & outcomes research 2012; 12: 399-410
• 19 Mahoney BA, Smith WA, Lo DS et al. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev; 2005 CD003235
• 20 Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin. S3-Leitlinie Intravasale Volumentherapie beim Erwachsenen. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/001-020l_S3_Intravasale_Volumentherapie_Erwachsenen_2014-09.pdf Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin.
• 21 Zafar MS, Wani JI, Karim R et al. Significance of serum magnesium levels in critically ill-patients. International journal of applied & basic medical research 2014; 4: 34-37
• 22 van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
• 23 Gomez H, Kellum JA. Lactate in sepsis. JAMA 2015; 313: 194-195
• 24 Jones AE, Shapiro NI, Trzeciak S et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010; 303: 739-746
• 25 Dettmer M, Holthaus CV, Fuller BM. The impact of serial lactate monitoring on emergency department resuscitation interventions and clinical outcomes in severe sepsis and septic shock: an observational cohort study. Shock 2015; 43: 55-61
• 26 Yealy DM, Kellum JA, Huang DT et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683-1693
• 27 Sankar V, Webster NR. Clinical application of sepsis biomarkers. J Anesth 2013; 27: 269-283
• 28 Garnacho-Montero J, Huici-Moreno MJ, Gutierrez-Pizarraya A et al. Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis. Crit Care 2014; 18: R116
• 29 Wacker C, Prkno A, Brunkhorst FM et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infectious diseases 2013; 13: 426-435
• 30 Schuetz P, Raad I, Amin DN. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Curr Opin Crit Care 2013; 19: 453-460
• 31 Jensen JU, Hein L, Lundgren B et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011; 39: 2048-2058
• 32 McLean AS, Tang B, Huang SJ. Investigating sepsis with biomarkers. BMJ 2015; 350: 254
• 33 Hochreiter M, Schroeder S. Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients. Anaesthesist 2011; 60: 661-673
• 34 Schuetz P, Chiappa V, Briel M et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011; 171: 1322-1331
• 35 Vincent JL, Donadello K, Schmit X. Biomarkers in the critically ill patient: C-reactive protein. Crit Care Clin 2011; 27: 241-251
• 36 Cozlea DL, Farcas DM, Nagy A et al. The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease. Current health sciences journal 2013; 39: 225-231
• 37 Oliveira CF, Botoni FA, Oliveira CR et al. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med 2013; 41: 2336-2343
• 38 Kumwilaisak K, Noto A, Schmidt UH et al. Effect of laboratory testing guidelines on the utilization of tests and order entries in a surgical intensive care unit. Crit Care Med 2008; 36: 2993-2999
• 39 Vezzani A, Zasa M, Manca T et al. Improving laboratory test requests can reduce costs in ICUs. Eur J Anaesthesiol 2013; 30: 134-136
• 40 Prat G, Lefevre M, Nowak E et al. Impact of clinical guidelines to improve appropriateness of laboratory tests and chest radiographs. Intensive Care Med 2009; 35: 1047-1053
• 41 Huck A, Lewandrowski K. Utilization management in the clinical laboratory: an introduction and overview of the literature. Clinica chimica acta; international journal of clinical chemistry 2014; 427: 111-117
• 42 Thomas KW. Right Test, Right Time, Right Patient. Crit Care Med 2014; 42: 190-192
• 43 Yeh DD. A clinicianʼs perspective on laboratory utilization management. Clinica chimica acta; international journal of clinical chemistry 2014; 427: 145-150